Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentrica Regulatory News (CNA)

Share Price Information for Centrica (CNA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 128.55
Bid: 129.05
Ask: 129.10
Change: 1.55 (1.22%)
Spread: 0.05 (0.039%)
Open: 127.90
High: 131.00
Low: 126.90
Prev. Close: 127.00
CNA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

13 Jan 2022 10:19

RNS Number : 3584Y
Centrica PLC
13 January 2022
 

 

Centrica plc

(the "Company")

 

Results of General Meeting regarding proposed sale of Spirit Energy's Norwegian business and interests in the Statfjord field and amended joint venture arrangements

Centrica plc held a general meeting ("General Meeting") in relation to the proposed sale of Spirit Energy's Norwegian business and interests in the Statfjord field and amended joint venture arrangements (the "Transaction") at Heathrow/Windsor Marriott Hotel, Ditton Road, Langley, Slough SL3 8PT at 9.00 a.m. on 13 January 2022. The resolution proposed at the General Meeting was decided on a poll and was passed. The results are set out below.

As previously announced, the completion of the Transaction remains subject to the satisfaction or waiver of the conditions summarised in the circular published in connection with the Transaction ("Circular"). The Transaction is expected to complete in the second quarter of 2022. 

The results are set out below:

Resolution

For*

%

Against

%

Total votes cast

% Issued Capital**

Withheld***

1.

To approve the Transaction as described in the Circular and to authorise the directors to give effect to the Transaction

3,840,949,656

99.94

2,317,646

0.06

3,843,267,302

65.35%

1,905,737

 

Notes to the disclosure:

*

Includes discretionary votes received

**

The total number of ordinary shares of 614/81 pence in issue, excluding shares held in treasury was 5,881,495,064 Shareholders are entitled to one vote per share.

***

A 'Vote withheld' is not a vote in law and is not counted towards the proportion of votes 'For' or 'Against' a resolution.

 

Copies of our announcements are available on our website: centrica.com/investors/rns-tools/rns-announcements

In accordance with Listing Rule 9.6.2, a copy of the resolution passed as special business has been submitted to the UK Listing Authority and will shortly be available for inspection at the National Storage Mechanism document viewing facility at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism

Enquiries:

Centrica

Investor and Analysts: Media Relations:

T: 01753 494900 T: 01784 84300

E: ir@centrica.com E: media@centrica.com

Goldman Sachs International (Sole Sponsor and Lead Financial Adviser)

Karen Cook, Mark Sorrell, Brian O'Keeffe, Bertie Whitehead+44 (0) 20 7774 1000

Robey Warshaw LLP (Financial Adviser)

Simon Robey+44 (0) 20 7317 3900

Cautionary statement

This announcement is not intended to, and does not constitute, or form part of, any offer to sell or an invitation to purchase or subscribe for any securities or a solicitation of any vote or approval in any jurisdiction. The information contained in this announcement is not for release, publication or distribution to persons in any jurisdiction where to do so might constitute a violation of local securities laws or regulations.

Important information relating to financial advisers

Goldman Sachs International ("Goldman Sachs"), which is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority in the United Kingdom, is acting exclusively as sponsor and lead financial adviser to Centrica and for no one else in connection with the Transaction and will not be responsible to anyone other than Centrica for providing the protections afforded to clients of Goldman Sachs or for providing advice in relation to the Transaction, the contents of this announcement or any transaction, arrangement or other matter referred to in this announcement.

Robey Warshaw LLP ("Robey Warshaw"), which is authorised and regulated in the U.K. by the FCA, is acting as financial adviser exclusively for Centrica and no one else in connection with the Transaction and will not be responsible to anyone other than Centrica for providing the protections afforded to clients of Robey Warshaw, nor for providing advice in relation to the Transaction or any other matters or arrangements referred to in this announcement.

 

Centrica plc is listed on the London Stock Exchange (CNA)

Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654

Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROMMZGMMGFVGZZM
Date   Source Headline
3rd May 20246:00 pmRNSTransaction in Own Shares
2nd May 20246:00 pmRNSTransaction in Own Shares
1st May 20246:00 pmRNSTransaction in Own Shares
1st May 20245:00 pmRNSBlock listing Interim Review
1st May 20244:30 pmRNSTotal Voting Rights
30th Apr 20246:00 pmRNSTransaction in Own Shares
29th Apr 20246:00 pmRNSTransaction in Own Shares
26th Apr 20246:00 pmRNSTransaction in Own Shares
25th Apr 20246:00 pmRNSTransaction in Own Shares
25th Apr 20245:30 pmRNSDirector/PDMR Shareholding
25th Apr 20242:00 pmRNSNotice of AGM
24th Apr 20246:00 pmRNSTransaction in Own Shares
23rd Apr 20246:00 pmRNSTransaction in Own Shares
22nd Apr 20246:00 pmRNSTransaction in Own Shares
19th Apr 20246:00 pmRNSTransaction in Own Shares
18th Apr 20246:00 pmRNSTransaction in Own Shares
17th Apr 20246:00 pmRNSTransaction in Own Shares
16th Apr 20246:00 pmRNSTransaction in Own Shares
15th Apr 20246:25 pmRNSTransaction in Own Shares
12th Apr 20246:00 pmRNSTransaction in Own Shares
11th Apr 20246:00 pmRNSTransaction in Own Shares
11th Apr 20241:30 pmRNSDirector/PDMR Shareholding
10th Apr 20246:00 pmRNSTransaction in Own Shares
9th Apr 20246:00 pmRNSTransaction in Own Shares
8th Apr 20246:00 pmRNSTransaction in Own Shares
8th Apr 20245:30 pmRNSDirector Declaration
4th Apr 20246:00 pmRNSTransaction in Own Shares
3rd Apr 20246:00 pmRNSTotal Voting Rights - Replacement
3rd Apr 20246:00 pmRNSTransaction in Own Shares
2nd Apr 20246:25 pmRNSTransaction in Own Shares
2nd Apr 20241:00 pmRNSTotal Voting Rights
28th Mar 20246:00 pmRNSTransaction in Own Shares
27th Mar 20246:25 pmRNSTransaction in Own Shares
26th Mar 20246:30 pmRNSTransfer of Treasury Shares
26th Mar 20246:00 pmRNSTransaction in Own Shares
26th Mar 20243:25 pmRNSDirector/PDMR Shareholding
26th Mar 20243:25 pmRNSDirector/PDMR Shareholding
26th Mar 20243:20 pmRNSAnnual Financial Report 2023
25th Mar 20246:00 pmRNSTransaction in Own Shares
25th Mar 20245:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20246:00 pmRNSTransaction in Own Shares
21st Mar 20246:00 pmRNSTransaction in Own Shares
20th Mar 20246:00 pmRNSTransaction in Own Shares
19th Mar 20246:00 pmRNSTransaction in Own Shares
18th Mar 20246:00 pmRNSTransaction in Own Shares
15th Mar 20246:26 pmRNSTransaction in Own Shares
14th Mar 20246:00 pmRNSTransaction in Own Shares
13th Mar 20246:25 pmRNSTransaction in Own Shares
12th Mar 20246:25 pmRNSTransaction in Own Shares
12th Mar 20245:45 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.